Megestrol

From Wikipedia, the free encyclopedia

Megestrol
Systematic (IUPAC) name
17-acetyl-17-hydroxy-6,10, 13-trimethyl-2,8,9,11,12,14,15,16- octahydro-1H-cyclopenta[ a] phenanthren-3-one
Identifiers
CAS number 3562-63-8
ATC code G03AC05 G03DB02, L02AB01
PubChem 19090
DrugBank APRD01092
Chemical data
Formula C22H30O3 
Mol. mass 342.472 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life 34 hours
Excretion  ?
Therapeutic considerations
Pregnancy cat.

contraindicated

Legal status
Routes  ?

Megestrol is a progesterone derivative with antineoplastic properties used in the treatment of advanced carcinoma of the breast and endometrium. When given in relatively high doses, Megestrol can substantially increase appetite in most individuals, even those with advanced cancer.

Megestrol Acetate Oral Suspension (a form of Megestrol) is used primarily as an appetite enhancer. The method of appetite enhancement is not known, but it can cause high blood sugar [1]. Currently, it is manufactured under the trade name Megace [2]

Languages